Designed for Resilience Against Emerging Mutations

The MassARRAY® SARS-CoV-2 Panel enables high-throughput, low-cost molecular detection with built-in resilience against the emergence of new variants. Available for in vitro diagnostic use under Emergency Use Authorization by the F.D.A. and CE-IVD marked in Europe.

Applications for the MassARRAY® System


Testing on the MassARRAY System

Discover how labs across the world use our core technology to achieve faster decisions and greater productivity in precision medicine.

The MassARRAY System is helping
genetics labs around the world, with:

  • Minimal Bioinformatics Analysis
  • Maximum Productivity
  • Flexible Biomarker Detection
  • Broad Multiplexing Range
  • Simple Workflow
  • Cost-Effective Testing

We think our customers say it best

Explore customer stories about rapid validation and lab expansion

Customer Success